IRONWOOD PHARMACEUTICALS, INC. (IRWD) Return on equity 2016–2022
IRONWOOD PHARMACEUTICALS, INC. (IRWD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
26.8%FY2022 · since FY2016: -122.5% → 26.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 26.8% | -60.4 pp |
| FY2021 | 87.2% | -82.3 pp |
| FY2020 | 169.5% | — |
| FY2017 | -1187.4% | -1064.9 pp |
| FY2016 | -122.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating marginIRWD Operating cash flowIRWD Free cash flowIRWD Capital expendituresIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →